Potassium Chloride in 5% Dextrose Injection, USP Label

First Page		Document Content
Date: 2015-01-09 15:43:06 Intravenous fluids Medical emergencies Dietary minerals Electrolyte disturbances Nephrology Hyperkalemia Potassium Hypoglycemia Intravenous therapy Medicine Chemistry Health		Potassium Chloride in 5% Dextrose Injection, USP Label Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 111,28 KB Share Document on Facebook

	California Naturopathic Medicine Committee - Intravenous Therapy Approved Providers DocID: 1tWfs - View Document
	FOR IMMEDIATE RELEASE FDA Approves Carnexiv™ (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types Carnexiv is the first FDA-approved intravenous carbamazepine option Health DocID: 1taCQ - View Document
	Intravenous infusion practice as a complex cognitive system: Exploring layers of Distributed Cognition Dominic Furniss 1 , Imogen Lyons 1 , Bryony DocID: 1rhqf - View Document
	Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform DocID: 1reFq - View Document
	Fresenius Kabi USA, LLC Three Corporate Drive Lake Zurich, IllinoisTTwww.fresenius-kabi.us DocID: 1r4t7 - View Document